HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.

AbstractBACKGROUND:
Muscular insulin resistance is frequently characterized by blunted increases in glucose-6-phosphate (G-6-P) reflecting impaired glucose transport/phosphorylation. These abnormalities likely relate to excessive intramyocellular lipids and mitochondrial dysfunction. We hypothesized that alterations in insulin action and mitochondrial function should be present even in nonobese patients with well-controlled type 2 diabetes mellitus (T2DM).
METHODS AND FINDINGS:
We measured G-6-P, ATP synthetic flux (i.e., synthesis) and lipid contents of skeletal muscle with (31)P/(1)H magnetic resonance spectroscopy in ten patients with T2DM and in two control groups: ten sex-, age-, and body mass-matched elderly people; and 11 younger healthy individuals. Although insulin sensitivity was lower in patients with T2DM, muscle lipid contents were comparable and hyperinsulinemia increased G-6-P by 50% (95% confidence interval [CI] 39%-99%) in all groups. Patients with diabetes had 27% lower fasting ATP synthetic flux compared to younger controls (p = 0.031). Insulin stimulation increased ATP synthetic flux only in controls (younger: 26%, 95% CI 13%-42%; older: 11%, 95% CI 2%-25%), but failed to increase even during hyperglycemic hyperinsulinemia in patients with T2DM. Fasting free fatty acids and waist-to-hip ratios explained 44% of basal ATP synthetic flux. Insulin sensitivity explained 30% of insulin-stimulated ATP synthetic flux.
CONCLUSIONS:
Patients with well-controlled T2DM feature slightly lower flux through muscle ATP synthesis, which occurs independently of glucose transport /phosphorylation and lipid deposition but is determined by lipid availability and insulin sensitivity. Furthermore, the reduction in insulin-stimulated glucose disposal despite normal glucose transport/phosphorylation suggests further abnormalities mainly in glycogen synthesis in these patients.
AuthorsJulia Szendroedi, Albrecht I Schmid, Marek Chmelik, Christian Toth, Attila Brehm, Martin Krssak, Peter Nowotny, Michael Wolzt, Werner Waldhausl, Michael Roden
JournalPLoS medicine (PLoS Med) Vol. 4 Issue 5 Pg. e154 (May 2007) ISSN: 1549-1676 [Electronic] United States
PMID17472434 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Glucose-6-Phosphate
  • Adenosine Triphosphate
Topics
  • Adenosine Triphosphate (biosynthesis)
  • Adipose Tissue (metabolism, physiology)
  • Adult
  • Aged
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (metabolism)
  • Fatty Acids, Nonesterified (metabolism)
  • Female
  • Glucose Clamp Technique
  • Glucose-6-Phosphate (blood)
  • Humans
  • Insulin Resistance (physiology)
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Mitochondria, Muscle (metabolism)
  • Obesity (metabolism, physiopathology)
  • Phosphorylation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: